← Back to Search

Behavioral Intervention

Gamified Attention Bias Modification for Depression

Q: Are individuals older than 25 years eligible to enroll in this research study?

<p>Individuals eligible for this study must be above 18 years of age and below the age of 70.</p>

Q: Are there currently any available slots for new participants in this medical trial?

<p>Per the details on clinicaltrials.gov, recruitment for this particular study is currently closed. The trial was first listed on 5/1/2024 and last updated on 4/8/2024. However, it's worth noting that out of the total number of ongoing trials, there are currently 1437 actively seeking participants.</p>

Phase < 1

Waitlist Available

Led By Christopher G Beevers, PhD

Research Sponsored by University of Texas at Austin

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, weeks 1-4 (acute period), weeks 12-28 (follow-up period)

Awards & highlights

Study Summary

This trial aims to compare two different treatments for depression in adults. The first aim is to see if a gamified treatment is more effective than a sham treatment. The second aim is to show that gam

Who is the study for?

This trial is for adults with symptoms of depression. Participants will be asked to fill out questionnaires, do eye-tracking tasks, and undergo interviews by clinicians. Details on specific inclusion or exclusion criteria are not provided.Check my eligibility

What is being tested?

The study tests two types of Attention Bias Modification (ABM) treatments: a gamified version and the traditional one, against a sham (inactive) treatment. It aims to see which ABM method is more effective at improving depression symptoms and how long the effects last.See study design

What are the potential side effects?

Potential side effects are not specified in this summary but generally, ABM interventions have minimal risks as they involve computer-based tasks designed to train attention patterns.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, weeks 1-4 (acute period), weeks 12-28 (follow-up period)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, weeks 1-4 (acute period), weeks 12-28 (follow-up period)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weeks 1-4 (acute period), weeks 12-28 (follow-up period) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

QIDS (Quick Inventory of Depression Symptoms) SR-16

Secondary outcome measures

Generalized Anxiety Disorder (GAD-7)

Hamilton Depression Rating Scale (HAM-D)

Perseverative Thinking Questionnaire (PTQ)

+2 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Gamified Attention Bias ModificationExperimental Treatment1 Intervention

This ABM variant will be completed on participants' mobile devices (iOS or Android). During app use, they will be presented with sad-happy stimulus pairs followed by target probes (tracing a path) always appearing at the happy stimulus location.

Group II: Traditional Attention Bias ModificationActive Control1 Intervention

This ABM variant is a web-based program delivered to participants via a computer. It presents pairs of stimuli to the right and left visual fields from two stimulus categories: sad or neutral facial expressions from the Pictures of Facial Affect (POFA) collection and dysphoric or neutral scenes from or from the International Affective Picture System (IAPS) collection.

Group III: Sham Attention Bias ModificationPlacebo Group1 Intervention

Sham and traditional ABM interventions will be identical in all respects with one critical exception. For sham ABM, after stimuli offset the target will appear with equal probability (50%) in the location of the neutral or the dysphoric stimulus.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor

353 Previous Clinical Trials

80,644 Total Patients Enrolled

30 Trials studying Depression

4,679 Patients Enrolled for Depression

Arcade TherapeuticsUNKNOWN

Christopher G Beevers, PhDPrincipal InvestigatorUT Austin

1 Previous Clinical Trials

500 Total Patients Enrolled

1 Trials studying Depression

500 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals older than 25 years eligible to enroll in this research study?

"Individuals eligible for this study must be above 18 years of age and below the age of 70."

Answered by AI

Are there currently any available slots for new participants in this medical trial?

"Per the details on clinicaltrials.gov, recruitment for this particular study is currently closed. The trial was first listed on 5/1/2024 and last updated on 4/8/2024. However, it's worth noting that out of the total number of ongoing trials, there are currently 1437 actively seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Confirmatory Efficacy Trial of Attention Bias Modification for Depression

2024. "Confirmatory Efficacy Trial of Attention Bias Modification for Depression". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06361095.

~400 spots leftby Mar 2028

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.